A study with ASP2151 in subjects with recurrent episodes of genital herpes

Journal of Drugs in Dermatology, Nov, 2007

Sponsored by Astellas Pharma Inc. This is a study of ASP2151 in subjects with recurrent outbreaks of genital herpes.

Condition         Intervention        Phase

Herpes Genitalis  Drug: ASP2151       Phase II
                  Drug: valacyclovir
                  Drug: placebo

Study ID Numbers: 15L-CL-101

ClinicalTrials.gov Identifier: NCT00486200

COPYRIGHT 2007 Journal of Drugs in Dermatology, Inc.
COPYRIGHT 2007 Gale Group

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale